Ultrapotent COVID-19 vaccine candidate designed via computer
An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections. Designed by scientists at the University of Washington School of Medicine in Seattle, the vaccine candidate has been transferred to two companies for clinical development.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Computers | Coronavirus | COVID-19 | Nanotechnology | Pandemics | Pharmaceuticals | University of Washington | Vaccines